Possible participation of nitric oxide in the increase of norepinephrine release caused by angiotensin peptides in rat atria

Hypertension

Volumn 29, Issue 6, 1997, Pages 1344-1350

  Gironacci, M M ^a   Lorenzo, P S ^b   Adler Graschinsky, Edda ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

angiotensin II; heart rate; nitric oxide; norepinephrine

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHRONOTROPISM; FEMALE; HEART RATE; HYPERTENSION; MUSCLE EXCITATION; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RADIOACTIVITY; RAT; STATISTICAL ANALYSIS;

EID: 0030945631     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.6.1344     Document Type: Article

References (48)

1. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991;18(suppl III):III-126-III-133.
2. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain. J Biol Chem. 1989;264:16518-16523.
3. Ferrario CM. Biological roles of angiotensin-(1-7). Hypertens Res. 1992;15:61-66.
4. Santos RAS, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, Ferrario CM. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension. 1988; 11(suppl I):I-153-I-157.
5. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993;52:1461-1480.
6. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamoneurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85:4095-4098.
7. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991;260:R1000-R1006.
8. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension. 1992;19(suppl II):II-49-II-55.
9. DelliPizzi AM, Hilchey SD, Bell Quilley CP. Natriuretic action of angiotensin-(1-7). Br J Pharmacol. 1994;111:1-3.
10. García N, Garvin J. Angiotensin-(1-7) has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol. 1994;5:1133-1138.
11. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996;270: F141-F147.
12. Felix D, Khosla MC, Barnes KL, Imboden H, Montani B, Ferrario CM. Neurophysiological responses to angiotensin (1-7). Hypertension. 1991;17:1111-1114.
13. Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB, Ferrario CM. Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol. 1989;257:H324-H329.
14. 3H]-norepinephrine from rat atria. Hypertension. 1994;24:457-460.
15. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci. 1986;38:1515-1519.
16. Fitzsimons JT. The effect of drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol. 1971;214:295-303.
17. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
18. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 1993;234: 35-42.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-142.
20. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger. Annu Rev Biochem. 1994;63:175-195.
21. ω-nitro-L-arginine, an inhibitor of nitric oxide synthesis, decreases noradrenaline outflow in rat isolated perfused mesenteric vasculature. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:238-240.
22. Yamamoto R, Wada A, Asada Y, Yuhi T, Yanagita T, Niina H, Sumiyoshi A. Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature. Naunyn Schmiedebergs Arch Pharmacol. 1994;349: 362-366.
23. Schnackenberg CG, Wilkins FC, Granger JP. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension. 1995;26: 1024-1029.
24. Zhang J, Van Meel JC, Pfaffendorf M, Zhang J, Van Zwieten PA. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur J Pharmacol. 1994;262:247-253.
25. Stewart JM, Young JD. Solid Phase Peptide Synthesis. Rockford, Ill: Pierce Chemical Co; 1984:76-80.
26. Adler-Graschinsky E, Langer SZ, Rubio MC. Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J Pharmacol Exp Ther. 1972;180:286-301.
27. 3H]-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol. 1973;22:1147-1151.
28. Rand MJ. Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol. 1992;19:147-169.
29. G-nitro-L-arginine on the contraction of the dog temporal artery elicited by transmural stimulation of noradrenergic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1991;343:221-224.
30. 3H]norepinephrine release. J Pharmacol Exp Ther. 1995;275:7-13.
31. G-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 1994;269:529-535.
32. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res. 1992; 70:607-611.
33. Thorin E, Atkinson J. Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery. Br J Pharmacol. 1994;111:351-357.
34. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension. 1996;27:36-42.
35. Murad F. The role of nitric oxide in modulating guanylyl cyclase. Neurotransmissions. 1994;10:1-4.
36. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
37. 3H]norepinephrine release from rat hippocampal slices. Neuropharmacology. 1995;34:723-729.
38. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
39. Porsti I, Hecker M, Bassenge E, Busse R. Dual actions of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1993;348:650-658.
40. McLay JS, Chatterjee PK, Mistry SK, Weerakody RP, Jardine AG, McKay NG, Hawsworth GM. Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells. Clin Sci. 1995;89:527-531.
41. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
42. Schwarz P, Diem R, Dun NJ, Förstemann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res. 1995;77:841-848.
43. Han X, Shimoni Y, Giles WR. An obligatory role for nitric oxide in autonomie control of mammalian heart rate. J Physiol. 1994;476: 309-314.
44. Adler-Graschinsky E, Langer SZ. Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol. 1975;53: 43-50.
45. Langer SZ, Rubio MC. Effects of the noradrenaline metabolites on the adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol. 1973;276:71-88.
46. Langer SZ. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1973;23:1793-1800.
47. Ten Eick R, Nawrath TF, MacDonald TF, Trautwein W. On the mechanism of the negative inotropic effect of acetylcholine. Pflugers Arch Physiol. 1976;361:207-211.
48. Mullane KM, Williams M. Adenosine and cardiovascular function. In: Williams M, ed. Adenosine and Adenosine Receptors. Clifton, NJ: The Humana Press; 1990:289.